January 06, 2025 02:44 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Bharatiya Janata Party releases first list of candidates for Delhi Assembly polls, fields Parvesh Sahib Singh Verma against Kejriwal | Firecracker unit explosion in Tamil Nadu's Virudhunagar kills 6 | Body of independent journalist, who went missing on Jan 1, found in a septic tank in Chhattisgarh | Delhi: 14-year-old student stabbed to death outside school after brawl with classmate | Rohit Sharma confirms he is not retiring amid speculations after skipping Sydney Test | India objects to China's 'new counties' announcement, says parts of these come under Ladakh | No cause for alarm over HMPV virus spread in China: Indian Health Agency | PM Modi gives a call for change in Delhi launching fierce attack on Arvind Kejriwal's AAP | Quran open to passage glorifying violence, bomb-making materials tracked in New Orleans attacker Shamshud-Din Jabbar's home | Jasprit Bumrah leads India in series decider after Rohit Sharma opts to rest in Sydney Test amid poor show with willow
India gives nod to two more anti-COVID-19 vaccines, one drug

India gives nod to two more anti-COVID-19 vaccines, one drug

Dec 28, 2021, at 07:04 pm

New Delhi/IBNS: Strengthening the fight against COVID-19, the Union Health Ministry on Tuesday gave nod to two more anti-COVID-19 vaccines and a drug to battle the deadly virus.

WHO grants emergency approval to Serum Insitute's COVID vaccine 'Covovax'

WHO grants emergency approval to Serum Insitute's COVID vaccine 'Covovax'

Dec 18, 2021, at 03:34 am

Geneva/IBNS: The World Health Organization (WHO) on Friday announced that  it has granted emergency approval to the India-manufactured COVID-19 vaccine Covovax.

Novavax may get approval in two months, likely to be costlier than Covishield

Novavax may get approval in two months, likely to be costlier than Covishield

Jul 01, 2021, at 02:28 am

New Delhi/IBNS: The Covovax shot developed by US vaccine-maker Novavax may be cleared for use in India between July and September, which would make it the fifth vaccine approved in the South Asian country.